Structure-activity relationship study of new carbazole sulfonamide derivatives as anticancer agents with dual-target mechanism

This publication has 25 references indexed in Scilit:

• Discovery of novel 6-p-tolyl-3-(3,4,5-trimethoxybenzyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine derivative as a potent tubulin inhibitor with promising in vivo antitumor activity
  European Journal of Medicinal Chemistry, 2023
• Optimization of carbazole carboxamide RORγt agonists: Challenges in improving the metabolic stability and maintaining the agonistic activity
  European Journal of Medicinal Chemistry, 2023
• IMB5476, a novel microtubule inhibitor, induces mitotic catastrophe and overcomes multidrug resistance in tumors
  European Journal of Pharmacology, 2022
• Current status of carbazole hybrids as anticancer agents
  European Journal of Medicinal Chemistry, 2022
• Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
  Drug Discovery Today, 2022
• Synthesis and structure-activity relationship study of water-soluble carbazole sulfonamide derivatives as new anticancer agents
  European Journal of Medicinal Chemistry, 2020
• Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy
  Medicinal Research Reviews, 2019
• Novel carbazole sulfonamide derivatives of antitumor agent: Synthesis, antiproliferative activity and aqueous solubility
  Bioorganic & Medicinal Chemistry Letters, 2017
• Novel pyridinyl and pyrimidinylcarbazole sulfonamides as antiproliferative agents
  Bioorganic & Medicinal Chemistry Letters, 2007
• Structural differences between brain beta 1‐ and beta 2‐tubulins: implications for microtubule assembly and colchicine binding.
  The EMBO Journal, 1985